Pfizer To Face Securities Fraud Suit Over Celebrex
Law360 ( February 2, 2009, 12:00 AM EST) -- Pfizer Inc. is back in the hot seat in a securities fraud class action accusing a company it acquired in 2003 of making materially false statements about a clinical study of blockbuster anti-inflammatory drug Celebrex....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.